Deal facts
- Buyer
- TA Associates (UK), LLP
- Target
- Advanced Medical Solutions Group plc
- Deal value
- Not disclosed
- Announced
- 15 May 2026
- Status
- Firm intention
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- Not stated
Sources
TA Associates (UK), LLP has agreed to acquire Advanced Medical Solutions Group plc in a transaction within the Healthcare sector. The deal was announced on 15 May 2026, with both the buyer and target operating from the United Kingdom. The specific consideration type and total deal value were not disclosed to the public at the time of the announcement. No details regarding the specific structure of the acquisition, such as whether it was a management buyout or a standard corporate purchase, were reported in the available data.
The transaction has subsequently been abandoned, meaning the acquisition did not proceed to completion. As the deal was never finalised, no completion date was recorded for the event. The status of the agreement remains closed without any further regulatory approval or integration steps being taken. This outcome indicates that the proposed arrangement between the private equity firm and the medical solutions group failed to materialise. The parties involved have not released further information regarding the reasons for the abandonment.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Firm intention
No Intention to Make an Offer for AMS
FOR IMMEDIATE RELEASE 15 May 2026 No intention to make an offer for AMS Further to the announcement on 18 April 2026 by Advanced Medical Solutions Group plc ("AMS") that funds affiliated with TA Associates (UK), LLP (together, "TA") were considering a possible offer for the entire issued and to be issued share capital of AMS, TA today confirms that it does not intend to mak
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Defender Opportunity LLC to acquire Non-Invasive Monitoring Systems, Inc.
Defender Opportunity LLC has agreed to acquire Non-Invasive Monitoring Systems, Inc. in a transaction structured as a loan note consideration. The deal was announced on…
- Buyer
- Defender Opportunity LLC
- Target
- Non-Invasive Monitoring Systems, Inc.
- Deal value
- Not disclosed
- Deal type
- unknown
Tooru PLC to acquire Mylky B.V
Tooru PLC has agreed to acquire Mylky B.V in a transaction within the Healthcare sector. The deal was announced on 29 May 2026, involving a buyer based in Great Britain…
- Buyer
- Tooru PLC
- Target
- Mylky B.V
- Deal value
- Not disclosed
- Deal type
- unknown
Toscafund Asset Management LLP to acquire Spire Healthcare Group plc
Toscafund Asset Management LLP has agreed to acquire Spire Healthcare Group plc in a proposed transaction within the UK healthcare sector. The deal, announced on 14 May…
- Buyer
- Toscafund Asset Management LLP
- Target
- Spire Healthcare Group plc
- Deal value
- Not disclosed
- Deal type
- unknown
KOHLBERG / MONTAGU to acquire TELEFLEX OEM BUSINESS
KOHLBERG / MONTAGU has agreed to acquire the TELEFLEX OEM Business in a transaction announced on 22 March 2026. The deal involves a company operating within the NaceV2Se…
- Buyer
- KOHLBERG / MONTAGU
- Target
- TELEFLEX OEM BUSINESS
- Deal value
- Not disclosed
- Deal type
- unknown
SK CAPITAL to acquire SWIXX BIOPHARMA
SK CAPITAL has agreed to acquire SWIXX BIOPHARMA in a transaction announced on 8 March 2026. The deal involves the biopharmaceutical sector, specifically within the whol…
- Buyer
- SK CAPITAL
- Target
- SWIXX BIOPHARMA
- Deal value
- Not disclosed
- Deal type
- unknown
Buyer history
TA Associates (UK), LLP
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive